What is the goal of drug treatment for transfusion-induced iron overload?

Updated: May 07, 2021
  • Author: Geneva E Guarin, MD, MBA; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The goals of pharmacotherapy in cases of transfusion-induced iron overload are to protect tissues from damage caused by iron, decrease plasma and cytosolic levels of reactive labile iron to normal, and rid the body of all excess iron, thereby preserving organ function. [13]  Three iron-chelating agents are available: deferoxamine, deferasirox, and deferiprone.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!